Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Portuguese
  • Polish

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Does a diverse microbiota lower the risk of diabetes?
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
General Medicine

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Does a diverse microbiota lower the risk of diabetes?
Gastroenterology

Does a diverse microbiota lower the risk of diabetes?

General Medicine Gastroenterology

A new study of over 2,000 subjects has found that a diverse intestinal microbiota and an abundance of 12 butyrate-producing taxa are linked to a lower risk of type 2 diabetes and insulin resistance.

Gastroenterology
Gynecology
Pediatrics
General Medicine
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

About this article

Created 07 December 2021
Updated 10 February 2025

Even though some studies had already made a link between the intestinal microbiota and type 2 diabetes (T2D), they were limited by a small sample size and there was ongoing debate as to the exact taxonomic units involved (results not always reproducible, insufficient power, etc.) This is why researchers decided to embark upon a large-scale study of 2,166 subjects taken from two Dutch cohorts, to investigate links between the composition of the intestinal microbiota (analyzed using bacterial 16S RNA gene sequencing and amplification on fecal samples) and T2D (verified by two physicians using WHO criteria (blood glucose, use of anti-diabetic drugs, etc.).

Even though it used a cross-sectional design (i.e., data about the microbiota and T2D collected at the same time), the analyses were adjusted for several confounders, such as energy intake, body mass index, education level, etc. Another strength and novel aspect of the study was the investigation of links between the microbiota and insulin resistance (IR), measured using fasting insulin and blood glucose, a significant subclinical parameter indicating an early stage in the pathogenesis of T2D.

Does a diverse microbiota strengthen protection?

Several indicators of microbiota (sidenote: α diversity A measure indicating the diversity of a single sample, i.e. the number of different species present in an individual. Hamady M, Lozupone C, Knight R. Fast UniFrac: facilitating high-throughput phylogenetic analyses of microbial communities including analysis of pyrosequencing and PhyloChip data. ISME J. 2010;4:17-27. https://www.nature.com/articles/ismej200997 ) were linked to lower IR and a reduced prevalence of T2D. In turn, (sidenote: β diversity A measure indicating the species diversity between samples, it allows to assess the variability of microbiota diversity between subjects. Hamady M, Lozupone C, Knight R. Fast UniFrac: facilitating high-throughput phylogenetic analyses of microbial communities including analysis of pyrosequencing and PhyloChip data. ISME J. 2010;4:17-27. https://www.nature.com/articles/ismej20099 ) was linked to IR. Finally, an abundance of seven taxonomic units - belonging to the Christensenellaceae and Ruminococcaceae families and the genus Marvinbryantia - were linked to a lower risk of IR, and an abundance of five other taxa - the Clostridiaceae and Peptostreptococcaceae families, and the genera Clostridium sensu stricto, Intestinibacter and Romboutsia – to a lower risk of T2D.

Butyrate-producing taxa that reduce the risk of T2D

These 12 taxonomic units, 10 of which have been linked for the first time to a lower risk of T2D or IR, are known to produce butyrate, a short-chain fatty acid produced by the breakdown of dietary fibers by bacteria. Enhanced mitochondrial activity, improved energy metabolism, and reduced endotoxemia and inflammation are some of the mechanisms put forward to explain these effects. However, ad hoc studies are still needed to validate its role in glucose metabolism and the prevention of diabetes.

Nevertheless, the links that have been identified between, on the one hand, microbiota diversity and an abundance of butyrate-producing bacteria, and on the other hand, a lower risk of IR and T2D, shed further light on the etiology, pathogenesis, and treatment of type 2 diabetes.

Sources

Chen Z, Radjabzadeh D, Chen L et al. Association of Insulin Resistance and Type 2 Diabetes With Gut Microbial Diversity: A Microbiome-Wide Analysis From Population Studies. JAMA Netw Open. 2021 Jul 1;4(7):e2118811.

Tags
Type 2 diabetes Insulin Butyrate Short-chain fatty acid Metabolism Microbiome Flora
    Created 07 December 2021
    Updated 10 February 2025

    About this article

    To know more about this topic.

    Medical practice

    General Medicine Gastroenterology

    Content type

    News

    Continue reading

    News
    Le microbiote intestinal, clé de la variabilité de la réponse aux statines
    19.09.2022

    Gut microbiota key to variability in statin response

    Read the article
    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine
    • English
    • Français
    • Español
    • Portuguese
    • Polish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    14.05.2025

    Towards worldwide redefinition of healthy vaginal microbiota

    Read the article
    07.05.2025

    The microbial-metabolic nexus in colon cancer

    Read the article
    02.05.2025

    A new lens on chlamydia: beyond behavior, into the microbiome

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    © 2025 Biocodex. All rights reserved.

    • Legal notice
    • GTU
    • Data protection policy
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo